Financial Report

Net sales Operating profit
Net sales Operating income
Profit attributable to owners of patent Operating profit margin
Ordinary profit margin
Net profit margin
Ordinary profit Net income attributable to owners of the parent
Overseas sales/Overseas sales ratio Capital expenditures
Depreciation and amortization
Research and development expenses
Operating income/Net sales, Ordinary profit/Net sales, Net profit margin Capital expenditures/Depreciation/R&D expenses



Key Financial Data (Last Five Years, Consolidated)

FY2025 FY2024 FY2023 FY2022 FY2021
Net sales
(Millions of yen)
 13,629 11,804 11,539 10,928 9,852
Operating profit
(Millions of yen)
 588 144 139 55 -859
Operating profit margin
（%）
 4.3 1.2 1.2 0.5 -8.7
Ordinary profit
(Millions of yen)
 679 212 204 211 -685
Ordinary profit margin
（%）
 5.0 1.8 1.8 1.9 -7.0
Profit attributable to owners of patent
(Millions of yen)
 395 1,459 438 246 -1,271
Net profit margin
（%）
 2.9 12.4 3.8 2.3 -12.9
Overseas sales
(Millions of yen)
 2,321 1,911 2,125 1,808 1,415
Overseas sales ratio
（%）
 17.0 16.2 18.4 16.5 14.4
Total assets
(Millions of yen)
 21,783 21,309 21,003 21,109 19,446
Net assets
(Millions of yen)
 16,603 15,914 14,110 13,386 12,720
Equity-to asset ratio
（%）
 74.5 73.3 65.8 62.0 64.1
Rate of return on equity
（%）
 2.5 9.9 3.3 1.9 -
Earnings per Share
(EPS, yen)
 38.00 138.77 41.68 23.82 -114.67
Book Value per Share
(BPS, yen)
 1,557.72 1,511.83 1,307.93 1,262.78 1,206.19
Payout ratio (Consolidated)
（%）
 57.9 21.6 24.0 21.0 -
Cash flows from operating activities
(Millions of yen)
 594 330 340 -230 -498
Cash flows from investing activities
(Millions of yen)
 -584 3,948 431 -160 -2
Cash flows from financing activities
(Millions of yen)
 -530 -2,273 -984 569 -374
Cash and cash equivalents at end of period
(Millions of yen)
 3,774 4,240 2,118 2,276 2,026
Capital expenditures
(Millions of yen)
 567 996 471 455 235
Depreciation and Amortization
(Millions of yen)
 714 631 576 543 798
R&D expenses
(Millions of yen)
 1,011 926 1,076 1,298 1,176